A phase I study of ADXS-503 alone and in combination with pembrolizumab in subjects with metastatic squamous or non-squamous non-small cell lung cancer (NSCLC).

被引：0

作者：

Ramalingam, Suresh S.

Stinchcombe, Tom

Gerstner, Gregory James

Haigentz, Missak

Vangala, Surya

Parsi, Megan

Heyburn, John W.

Kabala, Victor

Prasad, Tuhina

Gutierrez, Andres A.

Goldman, Jonathan Wade

机构：

[1] Emory Univ Hosp, Winship Canc Inst, 1364 Clifton Rd NE, Atlanta, GA 30322 USA

[2] Duke Canc Inst, Durham, NC USA

[3] Illinois Canc Care, Peoria, IL USA

[4] Atlantic Hlth Syst Canc Care, Morristown, NJ USA

[5] Advaxis Inc, Princeton, NJ USA

[6] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e21682

引用

页数：2